InnoCan Pharma Corporation

InnoCan Pharma Corporation

INNPF - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$5.8M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
InnoCan Pharma CorporationInnoCan Pharma Corporation-5.6--20%0.20.3

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$5.80 Million
Enterprise Value$1.03 Million
Earnings per Share$-0.25
Beta-0.22
Outstanding Shares4,498,772

Return

Return on Equity-19.67%ROE
Return on Assets-9.12%
Return on Invested Capital-13.26%

Valuation & Multiples

P/E Ratio-5.57P/E Ratio
PEG5.9PEG
Price to Sales0.25Price to Sales
Price to Book Ratio1.24Price to Book Ratio
Enterprise Value to Revenue0.04
Enterprise Value to EBIT-0.92
Enterprise Value to Net Income-2
Total Debt to Enterprise1.62
Debt to Equity0.35Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
September 2, 2026
EPS
-$0.01
Reported
Revenue
$5.12 M
Reported

Next Earnings Call

Expected Date
November 25, 2026
EPS Estimate
-
Consensus analyst estimate
Revenue Estimate
-
Consensus analyst estimate

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About InnoCan Pharma Corporation

11 employees
CEO: Iris Bincovich

InnoCan Pharma Corporation is a pharmaceutical enterprise dedicated to innovating drug delivery systems that integrate cannabidiol (CBD) with other pharmaceutical compounds. Its operations and development efforts span across the United S...